Under the leadership of CEO Ken Stiles and a long tenured executive team, Stiles is entering its next era — one defined by ...
Several drug development companies listed nearly $20 million in debt in Chapter 11 filings.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果